1. Home
  2. ACLS vs BLLN Comparison

ACLS vs BLLN Comparison

Compare ACLS & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$144.11

Market Cap

4.2B

Sector

Technology

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$93.91

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACLS
BLLN
Founded
1995
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.6B
IPO Year
2000
2025

Fundamental Metrics

Financial Performance
Metric
ACLS
BLLN
Price
$144.11
$93.91
Analyst Decision
Buy
Buy
Analyst Count
4
7
Target Price
$101.50
$126.71
AVG Volume (30 Days)
374.2K
795.0K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
103.40
EPS
1.05
0.48
Revenue
$839,048,000.00
$305,112,000.00
Revenue This Year
$1.93
$46.29
Revenue Next Year
$7.91
$30.14
P/E Ratio
$133.48
$194.44
Revenue Growth
N/A
99.97
52 Week Low
$73.60
$61.96
52 Week High
$193.78
$150.44

Technical Indicators

Market Signals
Indicator
ACLS
BLLN
Relative Strength Index (RSI) 53.58 37.20
Support Level $141.55 $73.46
Resistance Level $148.97 $99.29
Average True Range (ATR) 7.53 6.90
MACD 2.31 -4.42
Stochastic Oscillator 96.61 11.29

Price Performance

Historical Comparison
ACLS
BLLN

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: